Home Logon FTA Investment Managers Blog Subscribe About Us Contact Us

Search by Ticker, Keyword or CUSIP       
 
 


 

Key 3 Portfolio, Series 24
Ticker Symbol: FVJMOX

30 Holdings (As of Day of Deposit)
Ticker Compant Name Initial
Weight
Price*
Communication Services
GOOG Alphabet Inc. 3.33% $136.71
CMCSA Comcast Corporation 3.34% 44.56
EA Electronic Arts Inc. 3.34% 121.50
IPG The Interpublic Group of Companies, Inc. 3.34% 32.18
META Meta Platforms Inc. 3.38% 300.15
NFLX Netflix, Inc. 3.37% 448.68
OMC Omnicom Group Inc. 3.34% 79.67
TMUS T-Mobile US, Inc. 3.34% 136.89
TTWO Take-Two Interactive Software, Inc. 3.36% 141.18
DIS The Walt Disney Company 3.35% 81.19
Health Care
COR Cencora Inc. 3.35% 172.87
ELV Elevance Health Inc. 3.38% 450.15
HCA HCA Healthcare, Inc. 3.26% 274.25
JNJ Johnson & Johnson 3.32% 160.68
MCK McKesson Corporation 3.31% 407.13
MRK Merck & Co., Inc. 3.36% 107.51
PFE Pfizer Inc. 3.34% 35.38
TMO Thermo Fisher Scientific Inc. 3.39% 542.01
UNH UnitedHealth Group Incorporated 3.31% 480.81
VRTX Vertex Pharmaceuticals Incorporated 3.27% 348.26
Information Technology
ACN Accenture Plc 3.26% 326.16
AAPL Apple Inc. 3.32% 189.70
AMAT Applied Materials, Inc. 3.36% 153.61
ANET Arista Networks, Inc. 3.33% 197.46
AVGO Broadcom Inc. 3.27% 872.17
MSFT Microsoft Corporation 3.34% 333.55
NVDA NVIDIA Corporation 3.34% 485.48
ON ON Semiconductor Corporation 3.35% 99.31
PANW Palo Alto Networks, Inc. 3.37% 245.07
CRM Salesforce, Inc. 3.28% 218.69

*As of the close of business on 9/5/23.
Market values are for reference only and are not indicative of your individual cost basis.

Not FDIC Insured • Not Bank Guaranteed • May Lose Value

Portfolio Summary
Initial Date of Deposit 9/6/2023
Initial Public Offering Price $10.00 per Unit
Portfolio Ending Date 9/5/2025
Cash CUSIP 30332H728
Reinvestment CUSIP 30332H736
Fee Accounts Cash CUSIP 30332H744
Fee Accounts Reinvestment CUSIP 30332H751

Sales Charges (based on a $10 public offering price)
Standard Accounts
Transactional Sales Charges Initial: 0.00%
  Deferred: 2.25%
Creation & Development Fee (C&D Fee)   0.50%
Maximum Sales Charge   2.75%
Fee/Wrap Accounts
Maximum Sales Charge   0.50%

The deferred sales charge will be deducted in three monthly installments commencing 12/20/23. When the public offering price is less than or equal to $10.00 per unit, there will be no initial sales charge. If the price exceeds $10.00 per unit, you will pay an initial sales charge. The maximum sales charge for investors in fee accounts consists of the C&D fee. Investors in fee accounts are not assessed any transactional sales charges. Standard accounts sales charges apply to units purchased as an ineligible asset. The C&D fee is a charge of $0.050 per unit collected at the end of the initial offering period. If the price you pay exceeds $10.00 per unit, the C&D fee will be less than 0.50%; if the price you pay is less than $10.00 per unit, the C&D fee will exceed 0.50%. In addition to the sales charges listed, UITs are subject to annual operating expenses and organization costs.

You should consider the portfolio's investment objectives, risks, and charges and expenses carefully before investing. Contact your financial professional or call First Trust Portfolios, L.P. at 1.800.621.1675 to request a prospectus, which contains this and other information about the portfolio. Read it carefully before you invest.

Risk Considerations
An investment in this unmanaged unit investment trust should be made with an understanding of the risks involved with owning common stocks, such as an economic recession and the possible deterioration of either the financial condition of the issuers of the equity securities or the general condition of the stock market.

You should be aware that the portfolio is concentrated in stocks in the communication services, health care and information technology sectors which involves additional risks, including limited diversification. The companies engaged in the communication services sector are subject to rapidly changing technology, rapid product obsolescence, loss of patent protection, cyclical market patterns, governmental regulation, evolving industry standards and frequent new product introductions. Certain companies may be particularly susceptible to cybersecurity threats, which could have an adverse effect on their business. The companies engaged in the health care sector are subject to fierce competition, high research and development costs, governmental regulations, loss of patent protection, and changing consumer spending trends. In addition, health crises, such as a pandemic outbreak, can severely impact the health care industry in particular. The companies engaged in the information technology sector are subject to fierce competition, high research and development costs, and their products and services may be subject to rapid obsolescence. Technology company stocks, especially those which are Internet-related, may experience extreme price and volume fluctuations that are often unrelated to their operating performance.

Securities of non-U.S. issuers are subject to additional risks, including currency fluctuations, political risks, withholding, the lack of adequate financial information, and exchange control restrictions impacting non-U.S. issuers.

An investment in a portfolio containing mid-cap companies is subject to additional risks, as the share prices of certain mid-cap companies are often more volatile than those of larger companies due to several factors, including limited trading volumes, products, financial resources, management inexperience and less publicly available information.

Large capitalization companies may grow at a slower rate than the overall market.

As the use of Internet technology has become more prevalent in the course of business, the trust has become more susceptible to potential operational risks through breaches in cybersecurity.

In February 2022, Russia invaded Ukraine which has caused and could continue to cause significant market disruptions and volatility within the markets in Russia, Europe, and the United States. The hostilities and sanctions resulting from those hostilities could have a significant impact on certain investments as well as performance.

The ongoing effects of the COVID-19 global pandemic, or the potential impacts of any future public health crisis, may cause significant volatility and uncertainty in global financial markets. While vaccines have been developed, there is no guarantee that vaccines will be effective against future variants of the disease.

The value of the securities held by the trust may be subject to steep declines or increased volatility due to changes in performance or perception of the issuers.

This UIT is a buy and hold strategy and investors should consider their ability to hold the trust until maturity. There may be tax consequences unless units are purchased in an IRA or other qualified plan.

 

CUSIP identifiers have been provided by CUSIP Global Services, managed on behalf of the American Bankers Association by FactSet Research Systems Inc. and are not for use or dissemination in a manner that would serve as a substitute for any CUSIP service. The CUSIP Database, ©2024 CUSIP Global Services. "CUSIP" is a registered trademark of the American Bankers Association.

Fund Cusip Information
30332H728 (Cash)
30332H736 (Reinvest)
30332H744 (Cash-Fee)
30332H751 (Reinvest-Fee)
Printer Friendly Page Printer Friendly Page
 
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
Follow First Trust:  
First Trust Portfolios L.P.  Member SIPC and FINRA. (Form CRS)   •  First Trust Advisors L.P. (Form CRS)
Home |  Important Legal Information |  Privacy Policy |  California Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2024 All rights reserved.